Publications Database

King B. H. et al. (2001)

Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

40(6), pp. 658-665

Read Abstract (New Window)

Kolmen B. K. et al. (1995)

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.

Journal of the American Academy of Child and Adolescent Psychiatry

34(2), pp. 223-231

Read Abstract (New Window)

Kolmen B. K. et al. (1997)

Naltrexone in young autistic children: replication study and learning measures.

Journal of the American Academy of Child and Adolescent Psychiatry

36(11), pp. 1570-1578

Read Abstract (New Window)

Lecavalier L. et al. (2014)

Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder.

Journal of Autism and Developmental Disorders

May, 44(5), pp. 1128-1143.

Read Abstract (New Window) Read Full (New Window)

Lecavalier L. et al.

Parent stress in a randomized clinical trial of atomoxetine and parent training for children with autism spectrum disorder.

Journal of Autism and Developmental Disorders

Read Abstract (New Window)

Lubetsky M. J. et al. (2014)

Systems of care for individuals with autism spectrum disorder and serious behavioral disturbance through the lifespan.

Child and Adolescent Psychiatric Clinics of North America

January, 23(1), pp. 97-110.

Mahajan R. et al. (2012)

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

Pediatrics

130 S125-138

Read Abstract (New Window) Read Full (New Window)

Scahill L. et al. (2012)

Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Journal of the American Academy of Child and Adolescent Psychiatry

51(2), pp. 136-146

Read Abstract (New Window)

Smith T. et al. (2016)

Atomoxetine and parent training for children with autism and attention-deficit-hyperactivity disorder: A 24-week extension study.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

October, 55(10),

Read Abstract (New Window)

Varni J. W. et al. (2012)

Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: A post hoc analysis of two controlled trials.

Clinical Therapeutics

34(4), pp. 980-992.

Read Abstract (New Window)